Market Size, Competition Pattern and Future Development Forecast of China Animal Vaccine Market in 2016
This report is written elaborately based on the data from national level authoritative departments including the National Bureau of Statistics, General Administration of Customs , the MOA, China Institute of Veterinary Drug Control, China Veterinary Drug Association, China Animal Agricultural Association and industrial associations, the data are accurate and authoritative, moreover, this report integrates the views of experts, having high scientificity and prospectiveness. BOABC believes that the report is an important reference material for domestic and foreign animal vaccine manufacturers, investors, associations and research organizations to make strategic decision
CHAPTER ONE DEVELOPMENT COURSE AND POLICY ENVIRONMENT OF CHINA’S ANIMAL VACCINE INDUSTRY
1.1 Development course of China’s animal vaccine industry
1.2 Position and share of animal vaccine in China’s animal health product industry
1.3 Comparison between global and Chinese animal vaccine industry
1.4 Policy environment of China’s animal vaccine industry
1.4.1 “National Mid-and-long Term Plan for Animal Diseases Control”
1.4.2 China’s production policy for animal vaccine industry
1.4.3 Influence of compulsory immunization policy adjustment on China’s animal vaccine industry
1.4.4 China’s circulation policy for animal vaccine industry
1.4.5 China’s trade policy for animal vaccine industry
1.5 Development direction of China’s animal vaccine industry
CHAPTER TWO CHINA’S MARKET SIZE OF ANIMAL VACCINE INDUSTRY IN 2015MARKET SIZE OF CHINA’S ANIMAL VACCINE MARKET
2.1 China’s market size of animal vaccine market
2.1.1 Market size of domestic vaccine
2.1.2 Market size of foreign vaccine
2.2 China’s Market size of swine vaccine
2.2.1 China swine diseases epidemic situation analysis
2.2.2 China’s market size of swine vaccine
2.2.3 Market size of main swine vaccines
2.2.3.1 Market size and product features of FMD vaccine
2.2.3.2 Market size and product features of CSF vaccine
2.2.3.3 Market size and product features of PRRS vaccine
2.2.3.4 Market size and product features of PRV vaccine
2.2.3.5 Market size and product features of PCV2 vaccine
2.2.3.6 Market size of other vaccines
2.2.4 Market concentration of top 10 swine vaccine enterprises in China
2.3 China’s market size of poultry vaccine
2.3.1 China poultry diseases epidemic situation analysis
2.3.2 China’s market size of poultry vaccine
2.3.3 Market size of main poultry vaccines
2.3.3.1 Market size and product features of H5N1 vaccine
2.3.3.2 Market size and product features of ND vaccine
2.3.3.3 Market size and product features of MD vaccine
2.3.3.4 Market size and product features of IBD vaccine
2.3.3.5 Market size and product features of IB vaccine
2.3.3.6 Market size of other vaccines
2.3.4 Market concentration of top 10 poultry vaccine enterprises in China
2.4 China’s market size of ruminant vaccine
2.4.1 China’s ruminant diseases epidemic situation analysis
2.4.2 China’s market size of ruminant vaccine
2.4.3 Market size of main ruminant vaccines
2.4.3.1 Market size and product features of FMD vaccine
2.4.3.2 Market size and product features of brucellosis vaccine
2.4.3.3 Market size and product features of PPR vaccine
2.4.3.4 Market size of other vaccines
2.4.4 Market concentration of ruminant vaccine industry in China
2.5 China’s market size of other animal vaccines
CHAPTER THREE DEVELOPMENT TREND OF CHINA’S ANIMAL VACCINE INDUSTRY
3.1 Change trend of swine vaccine market size
3.1.1 Vaccine expense analysis of pig farms of different sizes
3.1.2 China’s breeding quantity of pigs in next decade
3.1.3 China’s scale level of pig breeding in next decade
3.1.4 Forecast on growth of market size of swine vaccine in next decade
3.2 Change trend of poultry vaccine market size
3.2.1 Vaccine expense analysis of chicken farms of different sizes
3.2.2 China’s breeding quantity of poultry in next decade
3.2.3 China’s scale level of poultry breeding in next decade
3.2.4 Forecast on growth of market size of poultry vaccine in next decade
3.3 Change trend of market size of other vaccines
3.3.1 Forecast on growth of market size of ruminant vaccine in next decade
3.3.2 Forecast on growth of market size of aquatic vaccine in next decade
3.3.3 Forecast on growth of market size of pet vaccine in next decade
CHAPTER FOUR ANALYSIS OF INDUSTRIAL CHAIN OF CHINA’S ANIMAL VACCINE INDUSTRY
4.1 R&D link
4.1.1 Main research institutions of China’s animal vaccine industry
4.1.2 Technology research and development mode of China’s animal vaccine industry
4.1.3 Technology research and development capacity of China’s animal vaccine industry
4.1.4 Summary of technology transfer of China’s main animal vaccines (research unit, transfer price and acceptor)
4.2 Production link
4.2.1 Number of animal vaccine enterprises in China
4.2.2 Capacity and output value of animal vaccine enterprises in China
4.2.3 Analysis of gross profit rate of China’s animal vaccine industry
4.2.4 Price analysis of China’s main animal vaccine products
4.2.5 Analysis of market concentration of China’s animal vaccine industry
4.3 Circulation link
4.3.1 Circulation ways of animal vaccine in China
4.3.2 Analysis of distribution channel of animal vaccine in China
4.3.3 Analysis of profit of animal vaccine dealers in China
4.3.4 Change trend of distribution channel of animal vaccine in China
CHAPTER FIVE ANALYSIS OF MAIN ANIMAL VACCINE ENTERPRISES IN CHINA
5.1 CAHIC
5.1.1 Company profile
5.1.2 Vaccine product mix
5.1.3 Animal vaccine sales revenue
5.1.4 Forecast on performance growth in next five years
5.2 JINYU BIO-TECHNOLOGY CO., LTD.
5.2.1 Company profile
5.2.2 Vaccine product mix
5.2.3 Animal vaccine sales revenue
5.2.4 Forecast on performance growth in next five years
5.3 PULIKE
5.3.1 Company profile
5.3.2 Vaccine product mix
5.3.3 Animal vaccine sales revenue
5.3.4 Forecast on performance growth in next five years
5.4 HILE
5.4.1 Company profile
5.4.2 Vaccine product mix
5.4.3 Animal vaccine sales revenue
5.4.4 Forecast on performance growth in next five years
5.5 Tianjin Ringpu
5.5.1 Company profile
5.5.2 Vaccine product mix
5.5.3 Animal vaccine sales revenue
5.5.4 Forecast on performance growth in next five years
5.6 CHOPPER
5.6.1 Company profile
5.6.2 Vaccine product mix
5.6.3 Animal vaccine sales revenue
5.6.4 Forecast on performance growth in next five years
5.7 TECON
5.7.1 Company profile
5.7.2 Vaccine product mix
5.7.3 Animal vaccine sales revenue
5.7.4 Forecast on performance growth in next five years
5.8 WINSUN
5.8.1 Company profile
5.8.2 Vaccine product mix
5.8.3 Animal vaccine sales revenue
5.8.4 Forecast on performance growth in next five years
5.9 CHINA AGRICULTURAL VET.BIO.SCIENCE and TECHNOLOGY CO., LTD.
5.9.1 Company profile
5.9.2 Vaccine product mix
5.9.3 Animal vaccine sales revenue
5.9.4 Forecast on performance growth in next five years
5.10 JILIN ZHENGYE BIOLOGICAL CO., LTD.
5.10.1 Company profile
5.10.2 Vaccine product mix
5.10.3 Animal vaccine sales revenue
5.10.4 Forecast on performance growth in next five years
CHAPTER SIX ANALYSIS OF MAIN FOREIGN ANIMAL VACCINE ENTERPRISES
6.1 Boehringer Ingelheim
6.1.1 Company profile
6.1.2 Vaccine product mix
6.1.3 Animal vaccine sales revenue
6.1.4 Forecast on performance growth in next five years
6.2 ZOETIS
6.2.1 Company profile
6.2.2 Vaccine product mix
6.2.3 Animal vaccine sales revenue
6.2.4 Forecast on performance growth in next five years
6.3 Merial
6.3.1 Company profile
6.3.2 Vaccine product mix
6.3.3 Animal vaccine sales revenue
6.3.4 Forecast on performance growth in next five years
6.4 HIPRA
6.4.1 Company profile
6.4.2 Vaccine product mix
6.4.3 Animal vaccine sales revenue
6.4.4 Forecast on performance growth in next five years
6.5 MSD
6.5.1 Company profile
6.5.2 Vaccine product mix
6.5.3 Animal vaccine sales revenue
6.5.4 Forecast on performance growth in next five years
1.1 Development course of China’s animal vaccine industry
1.2 Position and share of animal vaccine in China’s animal health product industry
1.3 Comparison between global and Chinese animal vaccine industry
1.4 Policy environment of China’s animal vaccine industry
1.4.1 “National Mid-and-long Term Plan for Animal Diseases Control”
1.4.2 China’s production policy for animal vaccine industry
1.4.3 Influence of compulsory immunization policy adjustment on China’s animal vaccine industry
1.4.4 China’s circulation policy for animal vaccine industry
1.4.5 China’s trade policy for animal vaccine industry
1.5 Development direction of China’s animal vaccine industry
CHAPTER TWO CHINA’S MARKET SIZE OF ANIMAL VACCINE INDUSTRY IN 2015MARKET SIZE OF CHINA’S ANIMAL VACCINE MARKET
2.1 China’s market size of animal vaccine market
2.1.1 Market size of domestic vaccine
2.1.2 Market size of foreign vaccine
2.2 China’s Market size of swine vaccine
2.2.1 China swine diseases epidemic situation analysis
2.2.2 China’s market size of swine vaccine
2.2.3 Market size of main swine vaccines
2.2.3.1 Market size and product features of FMD vaccine
2.2.3.2 Market size and product features of CSF vaccine
2.2.3.3 Market size and product features of PRRS vaccine
2.2.3.4 Market size and product features of PRV vaccine
2.2.3.5 Market size and product features of PCV2 vaccine
2.2.3.6 Market size of other vaccines
2.2.4 Market concentration of top 10 swine vaccine enterprises in China
2.3 China’s market size of poultry vaccine
2.3.1 China poultry diseases epidemic situation analysis
2.3.2 China’s market size of poultry vaccine
2.3.3 Market size of main poultry vaccines
2.3.3.1 Market size and product features of H5N1 vaccine
2.3.3.2 Market size and product features of ND vaccine
2.3.3.3 Market size and product features of MD vaccine
2.3.3.4 Market size and product features of IBD vaccine
2.3.3.5 Market size and product features of IB vaccine
2.3.3.6 Market size of other vaccines
2.3.4 Market concentration of top 10 poultry vaccine enterprises in China
2.4 China’s market size of ruminant vaccine
2.4.1 China’s ruminant diseases epidemic situation analysis
2.4.2 China’s market size of ruminant vaccine
2.4.3 Market size of main ruminant vaccines
2.4.3.1 Market size and product features of FMD vaccine
2.4.3.2 Market size and product features of brucellosis vaccine
2.4.3.3 Market size and product features of PPR vaccine
2.4.3.4 Market size of other vaccines
2.4.4 Market concentration of ruminant vaccine industry in China
2.5 China’s market size of other animal vaccines
CHAPTER THREE DEVELOPMENT TREND OF CHINA’S ANIMAL VACCINE INDUSTRY
3.1 Change trend of swine vaccine market size
3.1.1 Vaccine expense analysis of pig farms of different sizes
3.1.2 China’s breeding quantity of pigs in next decade
3.1.3 China’s scale level of pig breeding in next decade
3.1.4 Forecast on growth of market size of swine vaccine in next decade
3.2 Change trend of poultry vaccine market size
3.2.1 Vaccine expense analysis of chicken farms of different sizes
3.2.2 China’s breeding quantity of poultry in next decade
3.2.3 China’s scale level of poultry breeding in next decade
3.2.4 Forecast on growth of market size of poultry vaccine in next decade
3.3 Change trend of market size of other vaccines
3.3.1 Forecast on growth of market size of ruminant vaccine in next decade
3.3.2 Forecast on growth of market size of aquatic vaccine in next decade
3.3.3 Forecast on growth of market size of pet vaccine in next decade
CHAPTER FOUR ANALYSIS OF INDUSTRIAL CHAIN OF CHINA’S ANIMAL VACCINE INDUSTRY
4.1 R&D link
4.1.1 Main research institutions of China’s animal vaccine industry
4.1.2 Technology research and development mode of China’s animal vaccine industry
4.1.3 Technology research and development capacity of China’s animal vaccine industry
4.1.4 Summary of technology transfer of China’s main animal vaccines (research unit, transfer price and acceptor)
4.2 Production link
4.2.1 Number of animal vaccine enterprises in China
4.2.2 Capacity and output value of animal vaccine enterprises in China
4.2.3 Analysis of gross profit rate of China’s animal vaccine industry
4.2.4 Price analysis of China’s main animal vaccine products
4.2.5 Analysis of market concentration of China’s animal vaccine industry
4.3 Circulation link
4.3.1 Circulation ways of animal vaccine in China
4.3.2 Analysis of distribution channel of animal vaccine in China
4.3.3 Analysis of profit of animal vaccine dealers in China
4.3.4 Change trend of distribution channel of animal vaccine in China
CHAPTER FIVE ANALYSIS OF MAIN ANIMAL VACCINE ENTERPRISES IN CHINA
5.1 CAHIC
5.1.1 Company profile
5.1.2 Vaccine product mix
5.1.3 Animal vaccine sales revenue
5.1.4 Forecast on performance growth in next five years
5.2 JINYU BIO-TECHNOLOGY CO., LTD.
5.2.1 Company profile
5.2.2 Vaccine product mix
5.2.3 Animal vaccine sales revenue
5.2.4 Forecast on performance growth in next five years
5.3 PULIKE
5.3.1 Company profile
5.3.2 Vaccine product mix
5.3.3 Animal vaccine sales revenue
5.3.4 Forecast on performance growth in next five years
5.4 HILE
5.4.1 Company profile
5.4.2 Vaccine product mix
5.4.3 Animal vaccine sales revenue
5.4.4 Forecast on performance growth in next five years
5.5 Tianjin Ringpu
5.5.1 Company profile
5.5.2 Vaccine product mix
5.5.3 Animal vaccine sales revenue
5.5.4 Forecast on performance growth in next five years
5.6 CHOPPER
5.6.1 Company profile
5.6.2 Vaccine product mix
5.6.3 Animal vaccine sales revenue
5.6.4 Forecast on performance growth in next five years
5.7 TECON
5.7.1 Company profile
5.7.2 Vaccine product mix
5.7.3 Animal vaccine sales revenue
5.7.4 Forecast on performance growth in next five years
5.8 WINSUN
5.8.1 Company profile
5.8.2 Vaccine product mix
5.8.3 Animal vaccine sales revenue
5.8.4 Forecast on performance growth in next five years
5.9 CHINA AGRICULTURAL VET.BIO.SCIENCE and TECHNOLOGY CO., LTD.
5.9.1 Company profile
5.9.2 Vaccine product mix
5.9.3 Animal vaccine sales revenue
5.9.4 Forecast on performance growth in next five years
5.10 JILIN ZHENGYE BIOLOGICAL CO., LTD.
5.10.1 Company profile
5.10.2 Vaccine product mix
5.10.3 Animal vaccine sales revenue
5.10.4 Forecast on performance growth in next five years
CHAPTER SIX ANALYSIS OF MAIN FOREIGN ANIMAL VACCINE ENTERPRISES
6.1 Boehringer Ingelheim
6.1.1 Company profile
6.1.2 Vaccine product mix
6.1.3 Animal vaccine sales revenue
6.1.4 Forecast on performance growth in next five years
6.2 ZOETIS
6.2.1 Company profile
6.2.2 Vaccine product mix
6.2.3 Animal vaccine sales revenue
6.2.4 Forecast on performance growth in next five years
6.3 Merial
6.3.1 Company profile
6.3.2 Vaccine product mix
6.3.3 Animal vaccine sales revenue
6.3.4 Forecast on performance growth in next five years
6.4 HIPRA
6.4.1 Company profile
6.4.2 Vaccine product mix
6.4.3 Animal vaccine sales revenue
6.4.4 Forecast on performance growth in next five years
6.5 MSD
6.5.1 Company profile
6.5.2 Vaccine product mix
6.5.3 Animal vaccine sales revenue
6.5.4 Forecast on performance growth in next five years
